Loading asset research
Enlivex Ltd. Ordinary Shares
ENLVNasdaq · USD · StocksQuote as of · Exchange session not verified$0.95
-3.16%
Today
ENLV
Loading 1D prices…
Market cap
$16.8M
Volume
246.3K
52w high
$27.1552w low
$0.95Company profile
Enlivex Ltd. Ordinary Shares
Enlivex Ltd., together with its subsidiaries, operates as a clinical-stage macrophage reprogramming immunotherapy company in Israel. It offers AllocetraTM, a cell therapy designed to restore macrophage homeostasis, as well as develops AllocetraTM intra-articular injection for the treatment of knee osteoarthritis, which is in phase 1/2 trial; intra-articular AllocetraTM in osteoarthritis of the temporomandibular joint (TMJ); and Allocetra-OTS for the treatment of organ failure in adult sepsis patients, which is in phase 2. Enlivex Ltd. was formerly known as Enlivex Therapeutics Ltd. and changed its name to Enlivex Ltd. in February 2026. The company was founded in 2005 and is headquartered in Ness Ziona, Israel.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Ness Ziona, United States
Employees
34
Fiscal year end
1231
CIK
1596812
Session & valuation
Open$1.00
Previous close$0.981
Day high$1.07
Day low$0.95
30-day avg. volume288.4K
Outstanding shares237.4M
Diluted EPS$25.48
Latest annual period
P/E (trailing)0.00
P/E (forward)-1.23
Price / book0.01
Beta1.42
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| PBMPsyence Biomedical Ltd. Common Shares | $16.9M | $0.00 | — | $32.76 | +8.65% | Unrated |
| PDSBPDS Biotechnology Corporation Common Stock | $16.5M | $0.00 | — | -$0.74 | -6.44% | Buy |
| BIVIBioVie Inc. Class A Common Stock | $16.3M | $0.00 | — | -$3.05 | +1.05% | Unrated |
| AEONAEON Biopharma Inc. Class A Common Stock | $16.3M | $0.00 | — | -$3.95 | +12.76% | Buy |
| CTXRCitius Pharmaceuticals Inc. Common Stock | $15.9M | $7.1M | -695.59% | -$1.64 | -0.68% | Hold |